Part 7: Emerging Battlegrounds Cell and Gene Therapy, Trade Secret Thickets, and the Next Frontier Key Takeaways: Part 7 Cell and gene (C&G) therapies CAR-T, gene editing platforms, viral vector-based gene therapy, RNA therapies present a fundamentally different IP challenge than conventional pharmaceuticals
These systems include the various low molecular weight antioxidants such as reduced glutathione (GSH), vitamin C and vitamin E, bilirubin, and urate
Micropigmentation market report
Serious adverse events are rare with appropriate dosing and monitoring, though individual contraindications exist
Why rely on chance
Discussion GSSD is caused by genetic variations in GSS , which is located on chromosome 20q11.2, contains 13 exons, and is approximately 32 kb in length